Fresenius Kabi investing nearly $250 million to expand plant near Chicago
August 17, 2016
Fresenius Kabi is expanding its Melrose Park, Illinois site to significantly increase capacity for the production of injectable generic pharmaceuticals. The multi-stage expansion at the facility, just outside of Chicago, will include construction of a number of new buildings. Completion is scheduled for 2026, following an investment of nearly $250 million.